- Home
- TTNP vs UOKA Comparison
TTNP vs UOKA Comparison
Compare TTNP & UOKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- UOKA
- Stock Information
- Founded
- TTNP 1991
- UOKA 2002
- Country
- TTNP United States
- UOKA United Kingdom
- Employees
- TTNP N/A
- UOKA N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- UOKA
- Sector
- TTNP Health Care
- UOKA
- Exchange
- TTNP Nasdaq
- UOKA NYSE
- Market Cap
- TTNP 3.0M
- UOKA 2.8M
- IPO Year
- TTNP 1996
- UOKA N/A
- Fundamental
- Price
- TTNP $3.79
- UOKA $0.18
- Analyst Decision
- TTNP
- UOKA
- Analyst Count
- TTNP 0
- UOKA 0
- Target Price
- TTNP N/A
- UOKA N/A
- AVG Volume (30 Days)
- TTNP 41.9K
- UOKA 2.1M
- Earning Date
- TTNP 01-03-2025
- UOKA 02-16-2025
- Dividend Yield
- TTNP N/A
- UOKA N/A
- EPS Growth
- TTNP N/A
- UOKA N/A
- EPS
- TTNP N/A
- UOKA N/A
- Revenue
- TTNP N/A
- UOKA $114,849.00
- Revenue This Year
- TTNP N/A
- UOKA N/A
- Revenue Next Year
- TTNP N/A
- UOKA N/A
- P/E Ratio
- TTNP N/A
- UOKA N/A
- Revenue Growth
- TTNP N/A
- UOKA 289.97
- 52 Week Low
- TTNP $3.03
- UOKA $0.14
- 52 Week High
- TTNP $14.80
- UOKA $1.90
- Technical
- Relative Strength Index (RSI)
- TTNP 48.54
- UOKA N/A
- Support Level
- TTNP $3.14
- UOKA N/A
- Resistance Level
- TTNP $3.38
- UOKA N/A
- Average True Range (ATR)
- TTNP 0.22
- UOKA 0.00
- MACD
- TTNP 0.02
- UOKA 0.00
- Stochastic Oscillator
- TTNP 52.24
- UOKA 0.00
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About UOKA MDJM LTD
MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.